CompletedNCT04304755
Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD)
PHASE2 · 40 planned enrolment
- Countries listed
- 1
- Registry update
- April 5, 2024
immortal.lifeTrial registrations containing the exact intervention label Placebos.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 40 planned enrolment
PHASE3 · 150 planned enrolment
PHASE4 · 198 planned enrolment